New Delhi: Johnson & Johnson’s COVID-19 vaccine candidate’s late-stage study was paused as the company probes into a participant’s “unexplained illness”.
In a statement on Monday, the company said that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.
The halt in the trial is at least the second such pause to occur among several vaccine candidates that have reached large-scale final tests in the United States.
The company refused to divulge any more details about the illness, citing the participant’s privacy.
Cuttack: A promising youthful life ended in Cuttack on Sunday as a sophomore was electrocuted…
Mumbai: Ever since ‘Kantara’ became a phenomenal hit in 2022, movie lovers have been yearning…
Bhubaneswar: The husband of a sarpanch and a panchayat samiti member were critically injured as…
New Delhi: Pollution in the national Capital is going from bad to worse. As Delhi’s air…
Bhubaneswar: In order to streamline the road construction works, the Odisha government is planning to…
Patna: The trailer of ‘Pushpa 2: The Rule’, one of the year’s most anticipated films, is…
Patna: It was one of the most anticipated events in the Indian film industry -- the…
Bhubaneswar: With Odisha government taking a serious note of unnatural death of elephants, the Forest…